Why This Matters for Your Career
GSK is hiring 10 roles related to this product
THRIVE (nicotine polacrilex) by GSK. Approved for cholinergic nicotinic agonist [epc]. First approved in 2007.
Drug data last refreshed 18h ago
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Leadership ThriveCircles
Thrive Initiative Parent-Education Programming Study
ThriveCircles for Well-Being at CU SOM
The THRIVE Study: Teaching Healthy Regulation in Individuals & Vulnerable Environments
THRIVE-CAR-T Digital App
Worked on THRIVE at GSK? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
GSK is hiring 10 roles related to this product